Furthermore, UDCA has not been shown to activate FXR expression, but rather may antagonise it as demonstrated by a pharmacodynamic study and FXR binding experiments.46 It is therefore seems unlikely for UDCA to have had an impact on the gene expression profiles seen in PSC-IBD. The gene discussed is NR1H4; the disease is inflammatory bowel disease.